Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$338.27 - $413.0 $1.05 Million - $1.28 Million
-3,101 Reduced 70.59%
1,292 $511,000
Q4 2023

Feb 14, 2024

SELL
$318.29 - $392.21 $83,391 - $102,759
-262 Reduced 5.63%
4,393 $1.55 Million
Q3 2023

Nov 13, 2023

SELL
$354.9 - $412.41 $99,372 - $115,474
-280 Reduced 5.67%
4,655 $1.75 Million
Q2 2023

Aug 11, 2023

SELL
$334.63 - $382.47 $10,038 - $11,474
-30 Reduced 0.6%
4,935 $1.89 Million
Q1 2023

May 12, 2023

SELL
$232.5 - $346.47 $1.69 Million - $2.51 Million
-7,254 Reduced 59.37%
4,965 $1.72 Million
Q4 2022

Feb 13, 2023

SELL
$209.34 - $261.61 $6.25 Million - $7.81 Million
-29,858 Reduced 70.96%
12,219 $2.88 Million
Q3 2022

Nov 10, 2022

BUY
$246.08 - $343.65 $4.66 Million - $6.5 Million
18,921 Added 81.71%
42,077 $10.4 Million
Q2 2022

Aug 11, 2022

BUY
$280.61 - $420.45 $3.44 Million - $5.16 Million
12,266 Added 112.64%
23,156 $7 Million
Q1 2022

May 13, 2022

BUY
$357.49 - $445.92 $902,662 - $1.13 Million
2,525 Added 30.19%
10,890 $4.47 Million
Q4 2021

Feb 14, 2022

SELL
$402.25 - $471.34 $30.5 Million - $35.7 Million
-75,708 Reduced 90.05%
8,365 $3.92 Million
Q3 2021

Nov 12, 2021

SELL
$363.01 - $468.47 $1.27 Million - $1.64 Million
-3,495 Reduced 3.99%
84,073 $35.7 Million
Q2 2021

Aug 13, 2021

BUY
$284.77 - $363.2 $11.1 Million - $14.2 Million
39,073 Added 80.57%
87,568 $31.4 Million
Q1 2021

May 14, 2021

BUY
$257.29 - $307.53 $1.58 Million - $1.89 Million
6,132 Added 14.47%
48,495 $13.7 Million
Q4 2020

Feb 12, 2021

BUY
$261.16 - $301.66 $6.46 Million - $7.46 Million
24,718 Added 140.09%
42,363 $12 Million
Q3 2020

Nov 13, 2020

BUY
$224.99 - $288.02 $3.97 Million - $5.08 Million
17,645 New
17,645 $4.85 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.